Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.835
+0.085 (4.86%)
Oct 20, 2026, 11:30 AM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $78.81 million as of October 20, 2026. It is the 27,276th most valuable company in the world and the 4,335th biggest in the United States. Its market cap has increased by 27.25% in one year.
Market Cap
78.81M
Enterprise Value
79.18M
1-Year Change
27.25%
Global Rank
Country Rank
#4,335 United States
Category
ChartMarket Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $78.81M, a decrease of -94.09%. That is a compound annual growth rate of -37.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 78.81M | -13.54% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apyx Medical | 107.42M |
| Nyxoah | 96.77M |
| Hyperfine | 82.42M |
| Sera Prognostics | 80.08M |
| Lucid Diagnostics | 72.06M |
| Outset Medical | 71.43M |
| LENSAR | 70.64M |
| electroCore | 68.79M |